| Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins A González-Périz, R Horrillo, N Ferre, K Gronert, B Dong, ... The FASEB journal 23 (6), 1946, 2009 | 676 | 2009 |
| Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype E Titos, B Rius, A González-Périz, C López-Vicario, E Morán-Salvador, ... The Journal of Immunology 187 (10), 5408-5418, 2011 | 456 | 2011 |
| Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐and macrophage‐specific conditional knockouts E Morán‐Salvador, M López‐Parra, V García‐Alonso, E Titos, ... The FASEB Journal 25 (8), 2538-2550, 2011 | 404 | 2011 |
| 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity R Horrillo, A González-Périz, M Martínez-Clemente, M López-Parra, ... The journal of Immunology 184 (7), 3978-3987, 2010 | 160 | 2010 |
| Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis C López-Vicario, A González-Périz, B Rius, E Morán-Salvador, ... Gut 63 (2), 344-355, 2014 | 131 | 2014 |
| Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape. MJ Page A, Paoli P, Moran Salvador E, White 1, French J J Hepatol 64 (3), 661-73, 2016 | 127 | 2016 |
| Epigenetics and liver fibrosis E Moran-Salvador, J Mann Cellular and molecular gastroenterology and hepatology 4 (1), 125-134, 2017 | 118 | 2017 |
| Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells E Morán-Salvador, E Titos, B Rius, A González-Périz, V García-Alonso, ... Journal of hepatology 59 (5), 1045-1053, 2013 | 116 | 2013 |
| 5‐lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor α–induced hepatocyte damage in hyperlipidemia‐prone ApoE‐null mice M Martínez‐Clemente, N Ferré, A González‐Périz, M López‐Parra, ... Hepatology 51 (3), 817-827, 2010 | 114 | 2010 |
| Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis B Rius, E Titos, E Morán‐Salvador, C López‐Vicario, V García‐Alonso, ... The FASEB Journal 28 (2), 836-848, 2014 | 105 | 2014 |
| Resolution of inflammation in obesity-induced liver disease B Rius, C Lopez-Vicario, A Gonzalez-Periz, E Moran-Salvador, ... Frontiers in immunology 3, 257, 2012 | 100 | 2012 |
| Coordinate functional regulation between microsomal prostaglandin E synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor γ (PPARγ) in the conversion of white-to … V García-Alonso, C López-Vicario, E Titos, E Morán-Salvador, ... Journal of Biological Chemistry 288 (39), 28230-28242, 2013 | 80 | 2013 |
| A proof-of-concept for epigenetic therapy of tissue fibrosis: inhibition of liver fibrosis progression by 3-deazaneplanocin A M Zeybel, S Luli, L Sabater, T Hardy, F Oakley, J Leslie, A Page, ... Molecular Therapy 25 (1), 218-231, 2017 | 74 | 2017 |
| Disruption of the 12/15‐lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease M Martínez‐Clemente, N Ferré, E Titos, R Horrillo, A González‐Périz, ... Hepatology 52 (6), 1980-1991, 2010 | 69 | 2010 |
| Increased susceptibility to skin carcinogenesis in TREX2 knockout mice D Parra, J Manils, B Castellana, A Vina-Vilaseca, E Morán-Salvador, ... Cancer research 69 (16), 6676-6684, 2009 | 39 | 2009 |
| Fibrogenic activity of MECP2 is regulated by phosphorylation in hepatic stellate cells E Moran-Salvador, M Garcia-Macia, A Sivaharan, L Sabater, MYW Zaki, ... Gastroenterology 157 (5), 1398-1412. e9, 2019 | 31 | 2019 |
| Mecanismos básicos de lesión hepatocelular. Papel de los mediadores lipídicos de inflamación J Clària, R Horrillo, M Martínez-Clemente, E Morán-Salvador, E Titos, ... Gastroenterología y hepatología 31 (10), 682-692, 2008 | 7 | 2008 |
| Adipositas und Omega-3-Fettsäuren V Richter, M Blüher, U Ceglarek, J Thiery, M Hamm Adipositas-Ursachen, Folgeerkrankungen, Therapie 8 (01), 25-31, 2014 | 5 | 2014 |
| Basic mechanisms of hepatocellular injury. Role of inflammatory lipid mediators J Clària, R Horrillo, M Martínez-Clemente, E Morán-Salvador, E Titos, ... Gastroenterología y hepatología 31 (10), 682-692, 2008 | 5 | 2008 |
| 80 ROLE FOR PPAR γ IN HEPATIC STEATOSIS AS DETERMINED BY HEPATOCYTE AND KUPFFER CELL-SPECIFIC CONDITIONAL KNOCKOUTS USING CRE RECOMBINASE E Moran-Salvador, M López-Parra, E Titos, M Martínez-Clemente, ... Journal of Hepatology, S36-S37, 2010 | 3 | 2010 |
